Cite
HARVARD Citation
Rebhan, K. et al. (2022). Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review. Current opinion in urology. 32 (4), pp. 358-363. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rebhan, K. et al. (2022). Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review. Current opinion in urology. 32 (4), pp. 358-363. [Online].